Home » USA Broker Ratings » Aptose Biosciences – Consenus Indicates Potential 68.6% Upside

Aptose Biosciences – Consenus Indicates Potential 68.6% Upside

Aptose Biosciences with ticker code (APPS) have now 6 analysts covering the stock with the consensus suggesting a rating of ‘Strong_Buy’. The target price ranges between 12 and 7 with a mean TP of 9.88. Now with the previous closing price of 5.86 this would imply there is a potential upside of 68.6%. The day 50 moving average is 4.68 and the 200 moving average now moves to 6.56. The company has a market cap of $467m. Find out more information at: http://www.digitalturbine.com

Digital Turbine, through its subsidiaries, provides media and mobile communication products and solutions for mobile operators, application developers, device original equipment manufacturers (OEMs), and other third parties worldwide. It provides Ignite, a software platform that enables mobile operators and OEMs to control, manage, and monetize devices. The company offers other products and professional services directly related to the Ignite platform. Digital Turbine is headquartered in Austin, Texas.

Join us on our new LinkedIn page

Follow us on LinkedIn